Plaintiff

Zimmer US, Inc.

1 case as plaintiff.

Cases
1
Active
1
0 closed
Filed
2019
Top venue
D Del
1 case

Company profile

Zimmer US, Inc. is a U.S. operating subsidiary of Zimmer Biomet Holdings, Inc. (NYSE: ZBH), the orthopedic-device company headquartered in Warsaw, Indiana. The Zimmer business was founded in 1927 in Warsaw, was a Bristol-Myers Squibb subsidiary from 1972 until a 2001 spin-off (Zimmer Inc. profile; Zimmer "At a Glance," 2014), and merged with Biomet in 2015 to form Zimmer Biomet. Parent-level scale: roughly 17,000 employees and FY2024 net sales of about $7.7 billion (Zimmer Biomet Q4 2024 results; ZBH 10-K). Federal contracting records list Zimmer US, Inc. — Warsaw, IN — under NAICS 339112, surgical and medical instrument manufacturing.

Products / operations. Zimmer Biomet designs, manufactures and sells orthopedic reconstruction implants, chiefly knee and hip replacement systems, plus a "S.E.T." segment (surgical products, sports medicine, extremities and trauma) and dental/spine and related surgical offerings. MarketScreener's company summary reports about 25 production sites and sales in more than 100 countries. Zimmer US, Inc. is thus a practicing operating company, not a non-practicing entity or shell licensor.

Patent-litigation posture. The tracked data show one case, all as plaintiff and none as defendant, in the District of Delaware — consistent with an operating company asserting its own patents rather than a PAE monetizing an acquired portfolio. The single appearance arose inside a two-way dispute: Conformis, Inc. sued Zimmer Biomet entities first (D. Del., August 2019), and Zimmer US, Inc. and Biomet Manufacturing, LLC then filed their own infringement suit against Conformis on November 5, 2019 (1:19-cv-02093, D. Del., Judge Andrews).

Notable case. Zimmer US, Inc. et al. v. Conformis, Inc. involved patient-specific instrumentation for knee replacement. In May 2020 the parties settled all litigation: Zimmer Biomet paid Conformis $9.6 million and the companies cross-licensed patents covering patient-specific instruments and implants (Conformis press release/SEC filing; MassDevice; Orthopedics This Week). Venue was Delaware, not the Eastern District of Texas. The litigation posture reflects competition in patient-specific orthopedic instrumentation rather than NPE assertion activity.

Keep this research.

Save to your free workspace, then choose whether to receive updates.

Zimmer US, Inc. et al. v. Conformis, Inc.

pending
Docket:
1:19-cv-02093
Court:
D. Del.
Filed:
2019-11-05
Patents:8556983

Zimmer US and Zimmer Biomet filed a declaratory-judgment action against Conformis in the District of Delaware. The case was pending per the last docket update. Narrative states the '983 patent was not identified as asserted in this case.